HARBOUR INVESTMENTS, INC. - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 217 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
HARBOUR INVESTMENTS, INC. ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,949
-51.3%
2,2000.0%0.00%
Q3 2022$4,0000.0%2,2000.0%0.00%
Q2 2022$4,000
-33.3%
2,200
+83.3%
0.00%
Q4 2021$6,000
-88.7%
1,200
-82.6%
0.00%
-100.0%
Q3 2021$53,000
-19.7%
6,898
+1.1%
0.00%0.0%
Q2 2021$66,000
+13.8%
6,824
-2.8%
0.00%0.0%
Q1 2021$58,0007,0210.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Oaktree Fund Advisors, LLC 66,000$503,00048.93%
SABBY MANAGEMENT, LLC 1,698,107$12,957,0001.75%
EMFO, LLC 233,008$1,778,0001.57%
swisspartners Ltd. 110,000$839,0000.65%
HERITAGE WEALTH MANAGEMENT, LLC 150,000$1,145,0000.41%
Donald L. Hagan, LLC 42,929$328,0000.19%
COLLECTIVE FAMILY OFFICE LLC 44,203$337,0000.14%
Spectrum Wealth Advisory Group, LLC 18,093$138,0000.14%
NEXPOINT ASSET MANAGEMENT, L.P. 100,000$763,0000.13%
Cormorant Asset Management, LP 400,000$3,052,0000.12%
View complete list of SORRENTO THERAPEUTICS INC shareholders